BioAge Labs, Inc. (BIOA) Initiated with a Hold at William Blair
BioAge Labs, Inc. (BIOA – Research Report) received a Hold rating and price target from William Blair analyst Andy Hsieh today. The company’s ...
BIOAGE LABS (BIOA) Investors have until March 10 before the Expiration of the Class Action Deadline and are Urged to Contact BFA Law
New York, New York-- (Newsfile Corp. - March 5, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...
Le Lézard22h
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs
If you purchased or acquired securities in BioAge between September 26, 2024 and January 7, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...
Fintel on MSN5d
William Blair Initiates Coverage of BioAge Labs (BIOA) with Market Perform Recommendation
Fintel reports that on February 28, 2025, William Blair initiated coverage of BioAge Labs (NasdaqGS:BIOA) with a Market ...
Morningstar3d
BioAge Labs, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BIOA
NEW YORK, March 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of BioAge Labs, Inc. (NASDAQ: BIOA). Shareholders who purchased shares of BIOA during the ...
Morningstar3d
BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO– Hagens Berman
SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) is abandoning development of its lead obesity candidate, azelaprag, just weeks after halting a Phase 2 trial.
Macau Business4d
BIOA IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses...
Class Action, Consumer Services, GlobeNewswire, Law & Legal Issues | NEW YORK, March 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law ...
Investing6d
Bioage Labs Inc (BIOA)
BioAge Labs (BIOA) has filed for an upsized 10,500,000 share IPO at $17-$19 per share. The company previously indicated a 7.5M share offering in the same price range.
Investing2d
Bioage Labs Inc (BIOA)
New York, New York--(Newsfile Corp. - February 19, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc.... ByInvesting ...